Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

8

Other

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Type-1 angiotensin II receptor

8

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

8

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2011

8

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Hypertension

8

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

8

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Penetrant

8

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Takeda Pharmaceutical

8

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

9

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

9

FDA UNII

9

PUBCHEM

9

NCI_THESAURUS

5

SMS_ID

5

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

CARDIOVASCULAR SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANGIOTENSIN II ANTAGONISTS, COMBINATIONS

1

ANGIOTENSIN II ANTAGONISTS, PLAIN

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Angiotensin II antagonists and diuretics

1

Angiotensin II antagonists, plain

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

7

Principal Form

2

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 9 of 9 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

AZILSARTAN

F9NUX55P23

Export Data
Search for Structure

Status:

US Approved Rx (2025)

First approved in 2011

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Type-1 angiotensin II receptor

Type-1 angiotensin II receptor

Conditions:

TAK-536 (generic name: azilsartan) is an angiotensin II type 1 receptor blocker, discovered by Takeda and its mechanism of action is to lower blood pressure by inhibiting action of a vasopressor hormone Angiotensin II. Angiotensin II type 1 receptor...

antagonists have become an important drug class in the treatment of hypertension and heart failure. TAK-536 is in phase III clinical trial for treatment hypertension. This drug also known as active metabolite of the prodrug azilsartan medoxomil (also known as azilsartan kamedoxomil), but in some countries azilsartan rather than its prodrug is used for oral treatment.

2,4,6-TRICHLOROBENZOYL CHLORIDE

1083Y98L1D

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

AZILSARTAN MEPIXETIL

C2GK4G74Y7

Export Data
Search for Structure

Status:

US Approved Rx (2025)

First approved in 2011

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

Type-1 angiotensin II receptor

Type-1 angiotensin II receptor

Conditions:

TAK-536 (generic name: azilsartan) is an angiotensin II type 1 receptor blocker, discovered by Takeda and its mechanism of action is to lower blood pressure by inhibiting action of a vasopressor hormone Angiotensin II. Angiotensin II type 1 receptor...

antagonists have become an important drug class in the treatment of hypertension and heart failure. TAK-536 is in phase III clinical trial for treatment hypertension. This drug also known as active metabolite of the prodrug azilsartan medoxomil (also known as azilsartan kamedoxomil), but in some countries azilsartan rather than its prodrug is used for oral treatment.

AZILSARTAN MEPIXETIL SODIUM

UV3DFZ5794

Export Data
Search for Structure

Status:

US Approved Rx (2025)

First approved in 2011

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

Type-1 angiotensin II receptor

Type-1 angiotensin II receptor

Conditions:

TAK-536 (generic name: azilsartan) is an angiotensin II type 1 receptor blocker, discovered by Takeda and its mechanism of action is to lower blood pressure by inhibiting action of a vasopressor hormone Angiotensin II. Angiotensin II type 1 receptor...

antagonists have become an important drug class in the treatment of hypertension and heart failure. TAK-536 is in phase III clinical trial for treatment hypertension. This drug also known as active metabolite of the prodrug azilsartan medoxomil (also known as azilsartan kamedoxomil), but in some countries azilsartan rather than its prodrug is used for oral treatment.

AZILSARTAN MOPIVABIL SODIUM

J5YJZ74DH9

Export Data
Search for Structure

Status:

US Approved Rx (2025)

First approved in 2011

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Type-1 angiotensin II receptor

Type-1 angiotensin II receptor

Conditions:

TAK-536 (generic name: azilsartan) is an angiotensin II type 1 receptor blocker, discovered by Takeda and its mechanism of action is to lower blood pressure by inhibiting action of a vasopressor hormone Angiotensin II. Angiotensin II type 1 receptor...

antagonists have become an important drug class in the treatment of hypertension and heart failure. TAK-536 is in phase III clinical trial for treatment hypertension. This drug also known as active metabolite of the prodrug azilsartan medoxomil (also known as azilsartan kamedoxomil), but in some countries azilsartan rather than its prodrug is used for oral treatment.

AZILSARTAN MOPIVABIL

HZ9J3X3TUY

Export Data
Search for Structure

Status:

US Approved Rx (2025)

First approved in 2011

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Type-1 angiotensin II receptor

Type-1 angiotensin II receptor

Conditions:

TAK-536 (generic name: azilsartan) is an angiotensin II type 1 receptor blocker, discovered by Takeda and its mechanism of action is to lower blood pressure by inhibiting action of a vasopressor hormone Angiotensin II. Angiotensin II type 1 receptor...

antagonists have become an important drug class in the treatment of hypertension and heart failure. TAK-536 is in phase III clinical trial for treatment hypertension. This drug also known as active metabolite of the prodrug azilsartan medoxomil (also known as azilsartan kamedoxomil), but in some countries azilsartan rather than its prodrug is used for oral treatment.

AZILSARTAN TRIMETHYLETHANOLAMINE

6RDT9MR9SQ

Export Data
Search for Structure

Status:

US Approved Rx (2025)

First approved in 2011

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Type-1 angiotensin II receptor

Type-1 angiotensin II receptor

Conditions:

TAK-536 (generic name: azilsartan) is an angiotensin II type 1 receptor blocker, discovered by Takeda and its mechanism of action is to lower blood pressure by inhibiting action of a vasopressor hormone Angiotensin II. Angiotensin II type 1 receptor...

antagonists have become an important drug class in the treatment of hypertension and heart failure. TAK-536 is in phase III clinical trial for treatment hypertension. This drug also known as active metabolite of the prodrug azilsartan medoxomil (also known as azilsartan kamedoxomil), but in some countries azilsartan rather than its prodrug is used for oral treatment.

AZILSARTAN KAMEDOXOMIL

WEC6I2K1FC

Export Data
Search for Structure

Status:

US Approved Rx (2025)

First approved in 2011

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Type-1 angiotensin II receptor

Type-1 angiotensin II receptor

Conditions:

TAK-536 (generic name: azilsartan) is an angiotensin II type 1 receptor blocker, discovered by Takeda and its mechanism of action is to lower blood pressure by inhibiting action of a vasopressor hormone Angiotensin II. Angiotensin II type 1 receptor...

antagonists have become an important drug class in the treatment of hypertension and heart failure. TAK-536 is in phase III clinical trial for treatment hypertension. This drug also known as active metabolite of the prodrug azilsartan medoxomil (also known as azilsartan kamedoxomil), but in some countries azilsartan rather than its prodrug is used for oral treatment.

AZILSARTAN MEDOXOMIL

LL0G25K7I2

Export Data
Search for Structure

Status:

US Approved Rx (2025)

First approved in 2011

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Type-1 angiotensin II receptor

Type-1 angiotensin II receptor

Conditions:

TAK-536 (generic name: azilsartan) is an angiotensin II type 1 receptor blocker, discovered by Takeda and its mechanism of action is to lower blood pressure by inhibiting action of a vasopressor hormone Angiotensin II. Angiotensin II type 1 receptor...

antagonists have become an important drug class in the treatment of hypertension and heart failure. TAK-536 is in phase III clinical trial for treatment hypertension. This drug also known as active metabolite of the prodrug azilsartan medoxomil (also known as azilsartan kamedoxomil), but in some countries azilsartan rather than its prodrug is used for oral treatment.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1